Cargando…
Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers
Growing interest in i‐motif DNA as a transcriptional regulatory element motivates development of synthetic molecules capable of targeting these structures. In this study, we designed unmodified peptide nucleic acid (PNA) and gamma‐modified PNA (γPNA) oligomers complementary to an i‐motif forming seq...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078108/ https://www.ncbi.nlm.nih.gov/pubmed/36573547 http://dx.doi.org/10.1002/bip.23529 |
_version_ | 1785020444818014208 |
---|---|
author | Sarkar, Srijani Colón‐Roura, Gabriela Pearse, Alexander Armitage, Bruce A. |
author_facet | Sarkar, Srijani Colón‐Roura, Gabriela Pearse, Alexander Armitage, Bruce A. |
author_sort | Sarkar, Srijani |
collection | PubMed |
description | Growing interest in i‐motif DNA as a transcriptional regulatory element motivates development of synthetic molecules capable of targeting these structures. In this study, we designed unmodified peptide nucleic acid (PNA) and gamma‐modified PNA (γPNA) oligomers complementary to an i‐motif forming sequence derived from the promoter of the KRAS oncogene. Biophysical techniques such as circular dichroism (CD) spectroscopy, CD melting, and fluorescence spectroscopy demonstrated the successful invasion of the i‐motif by PNA and γPNA. Both PNA and γPNA showed very strong binding to the target sequence with high thermal stability of the resulting heteroduplexes. Interestingly fluorescence and CD experiments indicated formation of an intermolecular i‐motif structure via the overhangs of target‐probe heteroduplexes formed by PNA/γPNA invasion of the intramolecular i‐motif. Targeting promoter i‐motif forming sequences with high‐affinity oligonucleotide mimics like γPNAs may represent a new approach for inhibiting KRAS transcription, thereby representing a potentially useful anti‐cancer strategy. |
format | Online Article Text |
id | pubmed-10078108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100781082023-04-07 Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers Sarkar, Srijani Colón‐Roura, Gabriela Pearse, Alexander Armitage, Bruce A. Biopolymers Article Growing interest in i‐motif DNA as a transcriptional regulatory element motivates development of synthetic molecules capable of targeting these structures. In this study, we designed unmodified peptide nucleic acid (PNA) and gamma‐modified PNA (γPNA) oligomers complementary to an i‐motif forming sequence derived from the promoter of the KRAS oncogene. Biophysical techniques such as circular dichroism (CD) spectroscopy, CD melting, and fluorescence spectroscopy demonstrated the successful invasion of the i‐motif by PNA and γPNA. Both PNA and γPNA showed very strong binding to the target sequence with high thermal stability of the resulting heteroduplexes. Interestingly fluorescence and CD experiments indicated formation of an intermolecular i‐motif structure via the overhangs of target‐probe heteroduplexes formed by PNA/γPNA invasion of the intramolecular i‐motif. Targeting promoter i‐motif forming sequences with high‐affinity oligonucleotide mimics like γPNAs may represent a new approach for inhibiting KRAS transcription, thereby representing a potentially useful anti‐cancer strategy. John Wiley & Sons, Inc. 2022-12-27 2023-01 /pmc/articles/PMC10078108/ /pubmed/36573547 http://dx.doi.org/10.1002/bip.23529 Text en © 2022 The Authors. Biopolymers published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Article Sarkar, Srijani Colón‐Roura, Gabriela Pearse, Alexander Armitage, Bruce A. Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
title | Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
title_full | Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
title_fullStr | Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
title_full_unstemmed | Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
title_short | Targeting a KRAS i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
title_sort | targeting a kras i‐motif forming sequence by unmodified and gamma‐modified peptide nucleic acid oligomers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078108/ https://www.ncbi.nlm.nih.gov/pubmed/36573547 http://dx.doi.org/10.1002/bip.23529 |
work_keys_str_mv | AT sarkarsrijani targetingakrasimotifformingsequencebyunmodifiedandgammamodifiedpeptidenucleicacidoligomers AT colonrouragabriela targetingakrasimotifformingsequencebyunmodifiedandgammamodifiedpeptidenucleicacidoligomers AT pearsealexander targetingakrasimotifformingsequencebyunmodifiedandgammamodifiedpeptidenucleicacidoligomers AT armitagebrucea targetingakrasimotifformingsequencebyunmodifiedandgammamodifiedpeptidenucleicacidoligomers |